KR102056257B1 - 베타-턴 펩티도미메틱 사이클릭 염의 용액상 합성 및 결정화 - Google Patents
베타-턴 펩티도미메틱 사이클릭 염의 용액상 합성 및 결정화 Download PDFInfo
- Publication number
- KR102056257B1 KR102056257B1 KR1020187003965A KR20187003965A KR102056257B1 KR 102056257 B1 KR102056257 B1 KR 102056257B1 KR 1020187003965 A KR1020187003965 A KR 1020187003965A KR 20187003965 A KR20187003965 A KR 20187003965A KR 102056257 B1 KR102056257 B1 KR 102056257B1
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- compound
- side chain
- salt
- hcl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- XLNYIBCUNFHARO-UHFFFAOYSA-N CC(C)(C)OC(CCC(C(NC(CCCCNC(OC(C)(C)C)=O)C(NC(CCO)C(NCC(OC(C)(C)C)=O)=O)=O)=O)NC(c1cc([N+]([O-])=O)ccc1F)=O)=O Chemical compound CC(C)(C)OC(CCC(C(NC(CCCCNC(OC(C)(C)C)=O)C(NC(CCO)C(NCC(OC(C)(C)C)=O)=O)=O)=O)NC(c1cc([N+]([O-])=O)ccc1F)=O)=O XLNYIBCUNFHARO-UHFFFAOYSA-N 0.000 description 1
- ZZBQCIGXBDCUDJ-UHFFFAOYSA-N CC(C)(C)OC(CCC(C(NC(CCCCNC(OC(C)(C)C)=O)C(NC(CCOc(c1c2)ccc2[N+]([O-])=O)C(NCC(OC(C)(C)C)=O)=O)=O)=O)NC1=O)=O Chemical compound CC(C)(C)OC(CCC(C(NC(CCCCNC(OC(C)(C)C)=O)C(NC(CCOc(c1c2)ccc2[N+]([O-])=O)C(NCC(OC(C)(C)C)=O)=O)=O)=O)NC1=O)=O ZZBQCIGXBDCUDJ-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/30—Extraction; Separation; Purification by precipitation
- C07K1/306—Extraction; Separation; Purification by precipitation by crystallization
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1021—Tetrapeptides with the first amino acid being acidic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562190596P | 2015-07-09 | 2015-07-09 | |
| US62/190,596 | 2015-07-09 | ||
| PCT/EP2016/066281 WO2017005902A1 (en) | 2015-07-09 | 2016-07-08 | Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic salts |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20180036982A KR20180036982A (ko) | 2018-04-10 |
| KR102056257B1 true KR102056257B1 (ko) | 2019-12-16 |
Family
ID=56413639
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020187003965A Active KR102056257B1 (ko) | 2015-07-09 | 2016-07-08 | 베타-턴 펩티도미메틱 사이클릭 염의 용액상 합성 및 결정화 |
Country Status (8)
| Country | Link |
|---|---|
| US (4) | US10125165B2 (https=) |
| EP (2) | EP4549450A3 (https=) |
| JP (1) | JP6801835B2 (https=) |
| KR (1) | KR102056257B1 (https=) |
| CN (2) | CN107849089B (https=) |
| AU (1) | AU2016290654C1 (https=) |
| TW (1) | TWI708779B (https=) |
| WO (1) | WO2017005902A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6801835B2 (ja) * | 2015-07-09 | 2020-12-16 | ミメトゲン ファーマシュウティカルズ インコーポレイテッドMimetogen Pharmaceuticals, Inc. | β−ターンペプチド模倣環状塩の液相合成及び結晶化 |
| EP4067368A1 (en) | 2016-06-01 | 2022-10-05 | Athira Pharma, Inc. | Compounds |
| CA3098707A1 (en) * | 2018-05-31 | 2019-12-05 | Gap Peptides Llc | Method for solution-phase peptide synthesis and protecting strategies thereof |
| US11427612B2 (en) * | 2018-08-21 | 2022-08-30 | Wayne State University | Epimerization-free N to C solid-phase peptide synthesis |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPP254898A0 (en) * | 1998-03-24 | 1998-04-23 | University Of Queensland, The | Peptide turn mimetics |
| DE60123399T2 (de) | 2000-01-18 | 2007-08-23 | The Texas A & M University System, College Station | Pharmazeutische zubereitungen enthaltend beta-turn peptidomimetische zyklische substanzen |
| EP1517915B1 (en) * | 2002-06-11 | 2009-01-21 | Eli Lilly And Company | Prodrugs of excitatory amino acids |
| WO2009123761A1 (en) * | 2008-04-04 | 2009-10-08 | Mimetogen Pharmaceuticals Inc. | Beta-turn peptidomimetic cyclic compounds for treating dry eye |
| EP2400977B1 (en) * | 2009-02-27 | 2014-07-23 | Mimetogen Pharmaceuticals Inc. | Peptidomimetic cyclic compounds for treating retinitis pigmentosa |
| WO2012013281A1 (de) * | 2010-07-29 | 2012-02-02 | Merck Patent Gmbh | Flüssigkristallines medium enthaltend thiophenderivate |
| JP5710436B2 (ja) * | 2011-09-26 | 2015-04-30 | 株式会社東芝 | パターン形成方法 |
| EP2864347B1 (en) * | 2012-06-22 | 2020-10-28 | Mimetogen Pharmaceuticals, Inc. | Synthesis of beta-turn peptidomimetic cyclic compounds |
| JP6516974B2 (ja) * | 2013-06-14 | 2019-05-22 | 豊田合成株式会社 | ゴム組成物及びゴム製品 |
| WO2014204681A1 (en) * | 2013-06-20 | 2014-12-24 | Exxonmobil Chemical Patents Inc. | Long-bridged salen catalyst |
| JP6801835B2 (ja) * | 2015-07-09 | 2020-12-16 | ミメトゲン ファーマシュウティカルズ インコーポレイテッドMimetogen Pharmaceuticals, Inc. | β−ターンペプチド模倣環状塩の液相合成及び結晶化 |
-
2016
- 2016-07-08 JP JP2017567608A patent/JP6801835B2/ja active Active
- 2016-07-08 KR KR1020187003965A patent/KR102056257B1/ko active Active
- 2016-07-08 EP EP25158656.6A patent/EP4549450A3/en active Pending
- 2016-07-08 EP EP16739073.1A patent/EP3319978B1/en active Active
- 2016-07-08 WO PCT/EP2016/066281 patent/WO2017005902A1/en not_active Ceased
- 2016-07-08 AU AU2016290654A patent/AU2016290654C1/en active Active
- 2016-07-08 CN CN201680040450.0A patent/CN107849089B/zh active Active
- 2016-07-08 US US15/205,909 patent/US10125165B2/en active Active
- 2016-07-08 CN CN202210654769.XA patent/CN114874288A/zh active Pending
- 2016-07-11 TW TW105121814A patent/TWI708779B/zh active
-
2018
- 2018-11-08 US US16/184,485 patent/US11078234B2/en active Active
-
2021
- 2021-06-02 US US17/337,383 patent/US11753441B2/en active Active
-
2023
- 2023-07-18 US US18/354,076 patent/US12281179B2/en active Active
Non-Patent Citations (2)
| Title |
|---|
| J Org Chem.,71:6814-6821(2006.8.10.) |
| Mar Drugs.,3(5):3029-3045(2015.5.15.) |
Also Published As
| Publication number | Publication date |
|---|---|
| US20210300966A1 (en) | 2021-09-30 |
| US11078234B2 (en) | 2021-08-03 |
| EP3319978B1 (en) | 2025-02-19 |
| CN107849089A (zh) | 2018-03-27 |
| AU2016290654C1 (en) | 2021-11-11 |
| AU2016290654A2 (en) | 2020-08-06 |
| EP3319978C0 (en) | 2025-02-19 |
| CN107849089B (zh) | 2022-07-05 |
| EP4549450A3 (en) | 2025-07-02 |
| AU2016290654A1 (en) | 2018-01-25 |
| KR20180036982A (ko) | 2018-04-10 |
| US20170008923A1 (en) | 2017-01-12 |
| US20190194251A1 (en) | 2019-06-27 |
| US20230357318A1 (en) | 2023-11-09 |
| JP2018528928A (ja) | 2018-10-04 |
| US12281179B2 (en) | 2025-04-22 |
| CN114874288A (zh) | 2022-08-09 |
| CA2991661A1 (en) | 2017-01-12 |
| AU2016290654B2 (en) | 2021-07-08 |
| TW201716425A (zh) | 2017-05-16 |
| EP4549450A2 (en) | 2025-05-07 |
| US11753441B2 (en) | 2023-09-12 |
| EP3319978A1 (en) | 2018-05-16 |
| WO2017005902A1 (en) | 2017-01-12 |
| US10125165B2 (en) | 2018-11-13 |
| TWI708779B (zh) | 2020-11-01 |
| JP6801835B2 (ja) | 2020-12-16 |
| HK1255355A1 (en) | 2019-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12281179B2 (en) | Solution phase synthesis of β-turn peptidomimetic cyclic salts | |
| CN114630835B (zh) | 包含空间位阻大的氨基酸的肽化合物的制备方法 | |
| JP7430297B2 (ja) | N-アルキルアミノ酸、およびn-アルキルアミノ酸を含むペプチドの製造方法 | |
| KR20250133905A (ko) | 티르제파티드를 제조하기 위한 방법 및 중간체 | |
| CA2909584C (en) | Synthesis of beta-turn peptidomimetic cyclic compounds | |
| CA2991661C (en) | Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic salts | |
| HK40081202A (en) | Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic salts | |
| HK1255355B (en) | Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic salts | |
| HU197928B (en) | Process for the production poor in racemate of peptide intermediary of hormon synthesis of gonadorelin and gonadorelin analog | |
| EP3042911A1 (en) | Method for producing dipeptide derivative containing disubstituted amino acid residue | |
| KR20250160895A (ko) | 고리형 펩타이드의 공결정을 제조하는 방법 | |
| RU2574392C1 (ru) | СПОСОБ ПОЛУЧЕНИЯ ТРИПЕПТИДА ОБЩЕЙ ФОРМУЛЫ (I) HPyr-His-TrpOH, ИСПОЛЬЗУЕМОГО В КАЧЕСТВЕ ПРОМЕЖУТОЧНОГО СОЕДИНЕНИЯ (1-3 ФРАГМЕНТА) В СИНТЕЗЕ СИНТЕТИЧЕСКИХ АГОНИСТОВ ГОНАДОТРОПИН-РИЛИЗИНГ-ГОРМОНА (LH-RH), МЕТОДОМ ЖИДКОФАЗНОГО ПЕПТИДНОГО СИНТЕЗА БЕЗ ПОСТАНОВКИ И СНЯТИЙ ЗАЩИТНЫХ ГРУПП | |
| KR20110073473A (ko) | 펩티드 화합물 및 그의 제조 방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| R15-X000 | Change to inventor requested |
St.27 status event code: A-3-3-R10-R15-oth-X000 |
|
| R16-X000 | Change to inventor recorded |
St.27 status event code: A-3-3-R10-R16-oth-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| A201 | Request for examination | ||
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U12-oth-PR1002 Fee payment year number: 1 |
|
| PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 4 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 5 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 6 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 7 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE) Year of fee payment: 7 |